Market Place
Sourcing Support
Aditxt’s ADI Platform Advances Toward 1st-In-Human Clinical Trials
12 Dec 2024 //
BUSINESSWIRE
Aditxt Updates Equity Line, ATM Usage, & Shares Outstanding
08 Nov 2024 //
BUSINESSWIRE
Aditxt’s Target Acquisition Appili Announces Meeting Results
07 Nov 2024 //
BUSINESSWIRE
Appili Therapeutics Aligns with FDA on ATI-1801 NDA
31 Oct 2024 //
GLOBENEWSWIRE
Aditxt Completes Final Investment Under Merger Agreement
28 Oct 2024 //
BUSINESSWIRE
Aditxt Hosts Virtual Chat With CEOs Amro And Saundra Pelletier
21 Oct 2024 //
BUSINESSWIRE
Appili Shareholders Vote On Aditxt Acquisition November 6 2024
10 Oct 2024 //
BUSINESSWIRE
Aditxt Completes Third Parent Equity Investment With Evofem
08 Oct 2024 //
BUSINESSWIRE
Aditxt Delivers Shareholder Update and 2024 Year-End Plan
03 Oct 2024 //
BUSINESSWIRE
Aditxt Announces 1-for-40 Reverse Stock Split For October 2
27 Sep 2024 //
BUSINESSWIRE
Evofem Biosciences Files Proxy for Aditxt Acquisition Approval
24 Sep 2024 //
BUSINESSWIRE
Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem
20 Sep 2024 //
BUSINESSWIRE
Aditxt-Evofem Merger Set To Close In Q4 2024
09 Sep 2024 //
BUSINESSWIRE
Aditxt To Present At H.C. Wainwright Global Investment Conference
29 Aug 2024 //
BUSINESSWIRE
Waltz Health Launches Waltz Connect to Lower Costs of Specialty Medications
26 Aug 2024 //
BUSINESSWIRE
Aditxt Amends Arrangement Agreement With Appili Therapeutics
21 Aug 2024 //
BUSINESSWIRE
Aditxt Shareholders Approve All Proposals For 2024-2025 Plans
13 Aug 2024 //
BUSINESSWIRE
Appili Therapeutics Reports Q1 2025 Financial And Operational Results
13 Aug 2024 //
GLOBENEWSWIRE
Aditxt Subsidiary Seeks Award For Early Ovarian Cancer Detection Research
07 Aug 2024 //
BUSINESSWIRE
Aditxt Amends Appili Therapeutics Deal, Targets September 30 Closing
25 Jul 2024 //
BUSINESSWIRE
Aditxt And Evofem Amend Merger Agreement, Target September 30 Closing
17 Jul 2024 //
BUSINESSWIRE
Aditxt Prices $4.2M Private Placement At-The-Market Under Nasdaq
03 May 2024 //
BUSINESSWIRE
Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc
02 Apr 2024 //
BUSINESSWIRE
Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
02 Apr 2024 //
GLOBENEWSWIRE
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
02 Jan 2024 //
BUSINESSWIRE
In $100M deal, troubled Evofem sells itself to Aditxt
12 Dec 2023 //
FIERCE PHARMA
Aditxt, Inc. to Present at 8th Annual Dawson James Conference
06 Oct 2023 //
GLOBENEWSWIRE
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO
05 Oct 2023 //
BUSINESSWIRE
Aditxt Announces Participation at H.C. Wainwright 25th Investment Conference
08 Sep 2023 //
BUSINESSWIRE
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership
20 Apr 2023 //
BUSINESSWIRE
Aditxt Announces $1.9 M Registered Direct Offering Priced At-The-Marke
20 Apr 2023 //
BUSINESSWIRE
Aditxt Issues Shareholder Update
17 Apr 2023 //
BUSINESSWIRE
Aditxt Forms its Subsidiary Pearsanta for Growth of AditxtScore Program
14 Feb 2023 //
BUSINESSWIRE
Aditxt Forms Adimune Owned Subsidiary with aFocus on Immune Modulation Therapies
03 Jan 2023 //
BUSINESSWIRE
Aditxt’s Adimune Program Has Initiated Mfg Process of Immunotherapeutic Drug
21 Oct 2022 //
BUSINESSWIRE
Aditxt Announces Pricing of $20.0 Million Public Offering
16 Sep 2022 //
BUSINESSWIRE
Aditxt Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening
13 Sep 2022 //
BUSINESSWIRE
Aditxt Partners w/ Guthy-Renker Affiliate to Launch Consumer Awareness Campaign
14 Apr 2022 //
BUSINESSWIRE
Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M
05 Apr 2022 //
PRESS RELEASE
Aditxt to Participate in the 2022 Virtual Growth Conference
23 Mar 2022 //
BUSINESSWIRE
Aditxt Signs Share Exchange Agreement to Acquire AiPharma
28 Dec 2021 //
BUSINESSWIRE
Aditxt Extends Timeline to Sign Definitive Agreement to Acquire AiPharma Global
02 Dec 2021 //
BUSINESSWIRE
Aditxt Announces Pricing of $4.25 Million Public Offering
18 Oct 2021 //
BUSINESSWIRE
Ex-FDA officials ask SCOTUS to take up J&J talc case; and more
05 Oct 2021 //
ENDPTS
Aditxt Appoints Corinne Pankovcin as President and Thomas J. Farley as CFO
27 Sep 2021 //
BUSINESSWIRE
